News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines
Tuesday, October 04, 2022Bavarian Nordic AS announced an agreement with a Latin American country for the supply of the Companys monkeypox vaccine This is the Companys first bilateral supply agreement for the vaccine in Latin America outside the scope of the agreement entered...
Myrtelle and Forge Biologics Announce Viral Vector and Plasmid DNA cGMP Manufacturing Partnership
Tuesday, October 04, 2022Myrtelle Inc a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases and Forge Biologics a gene therapyfocused contract development and manufacturing organization today announced a manufact...
Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program
Friday, September 30, 2022Ventus Therapeutics Inc a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform announced today that it has entered into an exclusive worldwide license agreement with Novo Nordisk AS The agreement a...
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS
Friday, September 30, 2022Amylyx Pharmaceuticals Inc has received FDA approval for RELYVRIO sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis ALS in adults The drug demonstrated a significant slowing of physical function loss in ALS pat...
SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
Thursday, September 29, 2022An affiliate of investment firm SK Capital Partners LP announced today that it has entered into an agreement to acquire Apotex Pharmaceutical Holdings Inc a global pharmaceutical company based in Canada Apotex is recognized for its commitment to prod...
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
Thursday, September 29, 2022Odyssey Health Inc formerly known as Odyssey Group International Inc a company dedicated to developing innovative medical products that improve lives is pleased to announce
Ayala Pharmaceuticals Announces Fast Track Designation Granted by US FDA for AL102 in Progressing Desmoid Tumors
Wednesday, September 28, 2022Ayala Pharmaceuticals Inc a clinicalstage oncology company focused on developing and commercializing small molecule therapeutics for rare tumors and aggressive cancers has announced that the US Food and Drug Administration
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
Wednesday, September 28, 2022Pharming Group NV has announced that the US Food and Drug Administration FDA has accepted its New Drug Application NDA for leniolisib a selective phosphoinositide kinase delta PIK inhibitor for priority review Leniolisib is intended to treat primary...
SeraNovo and Ildong Pharmaceutical to Collaborate on Research Projects
Tuesday, September 27, 2022SeraNovo BV is excited to announce the successful completion of a multicompound agreement with Ildong Pharmaceutical a renowned pharmaceutical company based in Seoul South Korea Ildong Pharmaceutical focuses on the research and development of small m...
Innocoll and DURECT Announce U.S. launch of POSIMIR®
Tuesday, September 27, 2022Innocoll Pharmaceuticals Limited a biotechnology company and a portfolio business of Gurnet Point Capital along with DURECT Corporation Nasdaq DRRX has announced the recent commercial launch of POSIMIR bupivacaine solution in the United States POSIMI...
